What is myasthenia gravis in a 16-year-old male presenting with persistent unilateral ptosis?

What is Myasthenia Gravis?

Myasthenia gravis is a B-cell mediated autoimmune disorder that attacks the neuromuscular junction, causing variable muscle weakness that worsens with fatigue and improves with rest. 1

Disease Mechanism

The disorder occurs when acetylcholine receptor antibodies block neuromuscular transmission at the synapse between nerve and muscle. When an action potential triggers acetylcholine release, these pathogenic antibodies prevent effective binding to muscle receptors, resulting in progressively weaker muscle contractions with repeated use 1. The extraocular muscles are particularly vulnerable due to their unique twitch fiber composition and lower density of acetylcholine receptors 1.

Clinical Presentation in Your 16-Year-Old Patient

In a teenager presenting with persistent unilateral ptosis, myasthenia gravis should be strongly considered despite the asymmetric presentation. While typically bilateral, ocular myasthenia can present unilaterally 2, 3, 4.

Key Diagnostic Features to Look For:

Hallmark characteristics:

• Fatigability: Ptosis worsens with prolonged upgaze or as the day progresses
• Variability: Symptoms fluctuate in severity, often better in morning
• Cogan lid-twitch sign: Brief eyelid overshoot when refixating from downgaze to primary position
• Ice pack test positive: Applying ice for 2 minutes improves ptosis by ~2mm (highly specific) 1

Associated findings to assess:

• Double vision (diplopia) that changes pattern with fatigue
• Slow ocular saccades
• Variable strabismus that changes during prolonged examination
• Contralateral ptosis may worsen when manually elevating the more affected eyelid 1

Critical red flags requiring urgent evaluation:

• Difficulty swallowing, chewing, or slurred speech (bulbar involvement)
• Limb weakness or difficulty holding head up
• Respiratory fatigue or shortness of breath (can progress to life-threatening myasthenic crisis) 1

Diagnostic Workup

The diagnostic algorithm should proceed as follows:

1. Bedside testing (perform immediately):

   • Ice pack test: 2 minutes over closed eyes, look for ≥2mm ptosis improvement 1
   • Rest test: Have patient close eyes for 30 minutes, reassess ptosis
   • Fatigue testing: Sustained upgaze for 60 seconds to worsen ptosis

2. Serologic confirmation:

   • Anti-acetylcholine receptor antibodies (AChR-Ab): Positive in 80% of generalized MG but only 40-77% of ocular MG 1
   • If seronegative: Check anti-MuSK antibodies (positive in one-third of seronegative patients) 1
   • Consider LRP4 antibodies if both negative 1

3. Neurophysiologic testing:

   • Single-fiber electromyography: Gold standard, positive in >90% of ocular myasthenia 1
   • Repetitive nerve stimulation: Less sensitive (only 33% positive in ocular disease) 1

4. Imaging:

   • Chest CT: Essential to evaluate for thymoma (present in subset of patients, always requires thymectomy) 1

Natural History and Prognosis

Critical prognostic information for a 16-year-old:

• 50% of myasthenia patients present with isolated ocular symptoms (ptosis, diplopia, strabismus) 1
• 50-80% of those with ocular-only disease will progress to generalized myasthenia within 2-3 years 1
• Juvenile autoimmune myasthenia (onset in adolescence) follows similar patterns to adult disease 1
• Generalized disease can involve respiratory muscles, creating life-threatening respiratory failure risk 1

Management Approach

First-line medical treatment:

1. Pyridostigmine bromide (oral, 2-4 times daily): First-line symptomatic treatment, though only 50% of patients with ocular symptoms respond adequately 1

2. Corticosteroids: More effective than pyridostigmine, with 66-85% positive response rate 1

3. Immunosuppression: Azathioprine for steroid-sparing effect; newer agents like efgartigimod alfa-fcab (FDA-approved for AChR-antibody positive patients) may be offered by neurology 1

4. Thymectomy: Always indicated if thymoma present; also beneficial for specific age-based and immune-based subgroups even without thymoma 1

Important management caveats:

• Avoid certain anesthetic agents if respiratory muscle involvement present 1
• Prisms rarely help the variable diplopia 1
• Surgical correction of strabismus should wait 2-3 years until disease stabilizes 1
• Remission or stabilization possible after 2-3 years of treatment 1

Essential Referrals

Immediate coordination required:

• Neurology or neuro-ophthalmology: For definitive diagnosis and systemic management 1
• Ophthalmology: For ocular manifestations and surgical planning if needed 1
• Cardiothoracic surgery: If thymoma identified 1

Key Clinical Pitfalls

Do not miss these critical points:

• Pupillary involvement should NOT occur in myasthenia gravis; if pupils are affected, consider third nerve palsy instead 1
• Unilateral presentation does not exclude myasthenia - can remain asymmetric 2, 3, 4
• Normal antibody testing does not exclude disease - up to 50% of ocular myasthenia is seronegative 1
• Juvenile myasthenia is frequently misdiagnosed as congenital ptosis, third nerve palsy, or even Guillain-Barré syndrome 5, 6
• Early diagnosis and treatment significantly improve long-term prognosis and remission rates 3, 7